WRIP1_HUMAN - dbPTM
WRIP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID WRIP1_HUMAN
UniProt AC Q96S55
Protein Name ATPase WRNIP1
Gene Name WRNIP1 {ECO:0000312|HGNC:HGNC:20876}
Organism Homo sapiens (Human).
Sequence Length 665
Subcellular Localization Nucleus . Cytoplasm . Colocalizes with WRN in granular structures in the nucleus.
Protein Description Functions as a modulator of initiation or reinitiation events during DNA polymerase delta-mediated DNA synthesis. In the presence of ATP, stimulation of DNA polymerase delta-mediated DNA synthesis is decreased. Plays also a role in the innate immune defense against viruses. Stabilizes the RIG-I/DDX58 dsRNA interaction and promotes RIG-I/DDX58 'Lys-63'-linked polyubiquitination. In turn, RIG-I/DDX58 transmits the signal through mitochondrial MAVS..
Protein Sequence MEVSGPEDDPFLSQLHQVQCPVCQQMMPAAHINSHLDRCLLLHPAGHAEPAAGSHRAGERAKGPSPPGAKRRRLSESSALKQPATPTAAESSEGEGEEGDDGGETESRESYDAPPTPSGARLIPDFPVARSSSPGRKGSGKRPAAAAAAGSASPRSWDEAEAQEEEEAVGDGDGDGDADADGEDDPGHWDADAAEAATAFGASGGGRPHPRALAAEEIRQMLQGKPLADTMRPDTLQDYFGQSKAVGQDTLLRSLLETNEIPSLILWGPPGCGKTTLAHIIASNSKKHSIRFVTLSATNAKTNDVRDVIKQAQNEKSFFKRKTILFIDEIHRFNKSQQDTFLPHVECGTITLIGATTENPSFQVNAALLSRCRVIVLEKLPVEAMVTILMRAINSLGIHVLDSSRPTDPLSHSSNSSSEPAMFIEDKAVDTLAYLSDGDARAGLNGLQLAVLARLSSRKMFCKKSGQSYSPSRVLITENDVKEGLQRSHILYDRAGEEHYNCISALHKSMRGSDQNASLYWLARMLEGGEDPLYVARRLVRFASEDIGLADPSALTQAVAAYQGCHFIGMPECEVLLAQCVVYFARAPKSIEVYSAYNNVKACLRNHQGPLPPVPLHLRNAPTRLMKDLGYGKGYKYNPMYSEPVDQEYLPEELRGVDFFKQRRC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEVSGPEDDPF
----CCCCCCCCCHH
35.0128348404
54PhosphorylationHAEPAAGSHRAGERA
CCCCCCCCCCCHHHC
12.6928348404
62UbiquitinationHRAGERAKGPSPPGA
CCCHHHCCCCCCCCH
77.0427667366
65PhosphorylationGERAKGPSPPGAKRR
HHHCCCCCCCCHHHH
53.0125159151
66 (in isoform 3)Ubiquitination-34.1821890473
70AcetylationGPSPPGAKRRRLSES
CCCCCCHHHHCCCCC
52.9625953088
70UbiquitinationGPSPPGAKRRRLSES
CCCCCCHHHHCCCCC
52.9621906983
70 (in isoform 1)Ubiquitination-52.9621890473
70 (in isoform 2)Ubiquitination-52.9621890473
75PhosphorylationGAKRRRLSESSALKQ
CHHHHCCCCCCCCCC
33.3529255136
77PhosphorylationKRRRLSESSALKQPA
HHHCCCCCCCCCCCC
19.9629255136
78PhosphorylationRRRLSESSALKQPAT
HHCCCCCCCCCCCCC
33.3029255136
81SumoylationLSESSALKQPATPTA
CCCCCCCCCCCCCCC
54.69-
81UbiquitinationLSESSALKQPATPTA
CCCCCCCCCCCCCCC
54.6917550899
81 (in isoform 3)Ubiquitination-54.6921890473
85PhosphorylationSALKQPATPTAAESS
CCCCCCCCCCCCCCC
28.0527273156
87PhosphorylationLKQPATPTAAESSEG
CCCCCCCCCCCCCCC
33.8623927012
90 (in isoform 3)Ubiquitination-52.9421890473
91PhosphorylationATPTAAESSEGEGEE
CCCCCCCCCCCCCCC
29.0323401153
92PhosphorylationTPTAAESSEGEGEEG
CCCCCCCCCCCCCCC
40.9227273156
96 (in isoform 3)Ubiquitination-49.4621890473
98 (in isoform 4)Ubiquitination-77.9521890473
105PhosphorylationEGDDGGETESRESYD
CCCCCCCCCCCCCCC
42.4028450419
107PhosphorylationDDGGETESRESYDAP
CCCCCCCCCCCCCCC
49.0928450419
110PhosphorylationGETESRESYDAPPTP
CCCCCCCCCCCCCCC
27.4829255136
111PhosphorylationETESRESYDAPPTPS
CCCCCCCCCCCCCCC
16.0329255136
116PhosphorylationESYDAPPTPSGARLI
CCCCCCCCCCCCCCC
29.0929255136
118PhosphorylationYDAPPTPSGARLIPD
CCCCCCCCCCCCCCC
47.7930266825
124 (in isoform 4)Ubiquitination-41.6121890473
131PhosphorylationPDFPVARSSSPGRKG
CCCCCCCCCCCCCCC
25.9822199227
132PhosphorylationDFPVARSSSPGRKGS
CCCCCCCCCCCCCCC
34.6922199227
133PhosphorylationFPVARSSSPGRKGSG
CCCCCCCCCCCCCCC
32.4022199227
137UbiquitinationRSSSPGRKGSGKRPA
CCCCCCCCCCCCCCH
64.4422817900
139PhosphorylationSSPGRKGSGKRPAAA
CCCCCCCCCCCCHHH
44.1423403867
141AcetylationPGRKGSGKRPAAAAA
CCCCCCCCCCHHHHH
57.8325953088
141UbiquitinationPGRKGSGKRPAAAAA
CCCCCCCCCCHHHHH
57.8317550899
151PhosphorylationAAAAAAGSASPRSWD
HHHHHCCCCCCCCCC
22.3529255136
153PhosphorylationAAAAGSASPRSWDEA
HHHCCCCCCCCCCHH
23.6529255136
156PhosphorylationAGSASPRSWDEAEAQ
CCCCCCCCCCHHHHH
42.1128348404
203PhosphorylationAATAFGASGGGRPHP
HHHHHCCCCCCCCCH
38.0524275569
217 (in isoform 4)Ubiquitination-38.4521890473
225UbiquitinationIRQMLQGKPLADTMR
HHHHHCCCCCHHHCC
24.7321890473
225UbiquitinationIRQMLQGKPLADTMR
HHHHHCCCCCHHHCC
24.7323000965
225 (in isoform 1)Ubiquitination-24.7321890473
225 (in isoform 2)Ubiquitination-24.7321890473
239PhosphorylationRPDTLQDYFGQSKAV
CCCHHHHHHCCCCCC
9.17-
243 (in isoform 4)Ubiquitination-23.9821890473
244UbiquitinationQDYFGQSKAVGQDTL
HHHHCCCCCCCHHHH
38.9221963094
244 (in isoform 2)Ubiquitination-38.92-
249 (in isoform 4)Ubiquitination-33.1321890473
250PhosphorylationSKAVGQDTLLRSLLE
CCCCCHHHHHHHHHH
21.5827067055
252 (in isoform 4)Ubiquitination-3.6721890473
262 (in isoform 3)Ubiquitination-19.5321890473
272GlutathionylationILWGPPGCGKTTLAH
EEECCCCCCHHHHHH
6.6122555962
277 (in isoform 4)Ubiquitination-3.8521890473
286UbiquitinationHIIASNSKKHSIRFV
HHHHCCCCCCEEEEE
59.7721890473
286NeddylationHIIASNSKKHSIRFV
HHHHCCCCCCEEEEE
59.7732015554
286UbiquitinationHIIASNSKKHSIRFV
HHHHCCCCCCEEEEE
59.7721906983
286 (in isoform 1)Ubiquitination-59.7721890473
286 (in isoform 2)Ubiquitination-59.7721890473
287UbiquitinationIIASNSKKHSIRFVT
HHHCCCCCCEEEEEE
42.2622817900
288 (in isoform 3)Ubiquitination-31.9921890473
301UbiquitinationTLSATNAKTNDVRDV
EEECCCCCCCCHHHH
50.3521890473
3012-HydroxyisobutyrylationTLSATNAKTNDVRDV
EEECCCCCCCCHHHH
50.35-
301UbiquitinationTLSATNAKTNDVRDV
EEECCCCCCCCHHHH
50.3527667366
301 (in isoform 1)Ubiquitination-50.3521890473
301 (in isoform 2)Ubiquitination-50.3521890473
310UbiquitinationNDVRDVIKQAQNEKS
CCHHHHHHHHHCHHC
39.1521890473
310NeddylationNDVRDVIKQAQNEKS
CCHHHHHHHHHCHHC
39.1532015554
310UbiquitinationNDVRDVIKQAQNEKS
CCHHHHHHHHHCHHC
39.1527667366
310 (in isoform 1)Ubiquitination-39.1521890473
310 (in isoform 2)Ubiquitination-39.1521890473
316UbiquitinationIKQAQNEKSFFKRKT
HHHHHCHHCHHHHHE
61.1821890473
316AcetylationIKQAQNEKSFFKRKT
HHHHHCHHCHHHHHE
61.1825953088
316UbiquitinationIKQAQNEKSFFKRKT
HHHHHCHHCHHHHHE
61.1827667366
316 (in isoform 1)Ubiquitination-61.1821890473
316 (in isoform 2)Ubiquitination-61.1821890473
320UbiquitinationQNEKSFFKRKTILFI
HCHHCHHHHHEEEEH
51.4822817900
322UbiquitinationEKSFFKRKTILFIDE
HHCHHHHHEEEEHHH
40.2717550899
335UbiquitinationDEIHRFNKSQQDTFL
HHHHHCCHHHCCCCC
47.1017550899
336 (in isoform 2)Phosphorylation-33.8921406692
345 (in isoform 2)Phosphorylation-6.5121406692
370PhosphorylationQVNAALLSRCRVIVL
HHHHHHHHCCEEEEE
30.13-
381 (in isoform 3)Ubiquitination-32.7321890473
387PhosphorylationLPVEAMVTILMRAIN
CCHHHHHHHHHHHHH
8.7024043423
395PhosphorylationILMRAINSLGIHVLD
HHHHHHHHCCCEECC
23.1224043423
403PhosphorylationLGIHVLDSSRPTDPL
CCCEECCCCCCCCCC
24.8824043423
404PhosphorylationGIHVLDSSRPTDPLS
CCEECCCCCCCCCCC
41.7824043423
407 (in isoform 3)Ubiquitination-49.4921890473
413PhosphorylationPTDPLSHSSNSSSEP
CCCCCCCCCCCCCCC
28.0424247654
413 (in isoform 3)Ubiquitination-28.0421890473
416 (in isoform 3)Ubiquitination-36.8721890473
434PhosphorylationKAVDTLAYLSDGDAR
CHHHEEECCCCCCHH
15.1729449344
436PhosphorylationVDTLAYLSDGDARAG
HHEEECCCCCCHHCC
27.2029449344
439UbiquitinationLAYLSDGDARAGLNG
EECCCCCCHHCCCCH
37.5622505724
441 (in isoform 3)Ubiquitination-33.6521890473
457UbiquitinationAVLARLSSRKMFCKK
HHHHHHHCCCCCCCC
40.2821890473
457UbiquitinationAVLARLSSRKMFCKK
HHHHHHHCCCCCCCC
40.2823000965
457 (in isoform 2)Ubiquitination-40.2821890473
464UbiquitinationSRKMFCKKSGQSYSP
CCCCCCCCCCCCCCC
62.0822505724
465PhosphorylationRKMFCKKSGQSYSPS
CCCCCCCCCCCCCCC
27.7929396449
468PhosphorylationFCKKSGQSYSPSRVL
CCCCCCCCCCCCCEE
30.9725159151
469PhosphorylationCKKSGQSYSPSRVLI
CCCCCCCCCCCCEEE
19.4029396449
470PhosphorylationKKSGQSYSPSRVLIT
CCCCCCCCCCCEEEE
22.9621815630
472PhosphorylationSGQSYSPSRVLITEN
CCCCCCCCCEEEECC
29.1328985074
477PhosphorylationSPSRVLITENDVKEG
CCCCEEEECCHHHHH
25.2826074081
482SumoylationLITENDVKEGLQRSH
EEECCHHHHHHHHHC
49.26-
482SumoylationLITENDVKEGLQRSH
EEECCHHHHHHHHHC
49.2628112733
482UbiquitinationLITENDVKEGLQRSH
EEECCHHHHHHHHHC
49.2623000965
482 (in isoform 1)Ubiquitination-49.2621890473
483UbiquitinationITENDVKEGLQRSHI
EECCHHHHHHHHHCC
66.0521890473
483UbiquitinationITENDVKEGLQRSHI
EECCHHHHHHHHHCC
66.0523000965
483 (in isoform 2)Ubiquitination-66.0521890473
500PhosphorylationDRAGEEHYNCISALH
CCCCHHHHHHHHHHH
18.2725884760
504PhosphorylationEEHYNCISALHKSMR
HHHHHHHHHHHHHHC
27.2928152594
508UbiquitinationNCISALHKSMRGSDQ
HHHHHHHHHHCCCCH
46.9623000965
508 (in isoform 1)Ubiquitination-46.9621890473
511MethylationSALHKSMRGSDQNAS
HHHHHHHCCCCHHHH
48.86115920089
534PhosphorylationEGGEDPLYVARRLVR
HCCCCHHHHHHHHHH
9.4620090780
562PhosphorylationLTQAVAAYQGCHFIG
HHHHHHHHCCCCCCC
8.8322817900
576UbiquitinationGMPECEVLLAQCVVY
CCCHHHHHHHHHHHH
1.2121890473
576UbiquitinationGMPECEVLLAQCVVY
CCCHHHHHHHHHHHH
1.2123000965
576 (in isoform 2)Ubiquitination-1.2121890473
594PhosphorylationAPKSIEVYSAYNNVK
CCCCEEHHHHHCCHH
3.7728152594
595PhosphorylationPKSIEVYSAYNNVKA
CCCEEHHHHHCCHHH
29.4728152594
597PhosphorylationSIEVYSAYNNVKACL
CEEHHHHHCCHHHHH
11.0028152594
601UbiquitinationYSAYNNVKACLRNHQ
HHHHCCHHHHHHHCC
35.1923000965
601 (in isoform 1)Ubiquitination-35.1921890473
602UbiquitinationSAYNNVKACLRNHQG
HHHCCHHHHHHHCCC
8.0321890473
602UbiquitinationSAYNNVKACLRNHQG
HHHCCHHHHHHHCCC
8.0323000965
602 (in isoform 2)Ubiquitination-8.0321890473
608UbiquitinationKACLRNHQGPLPPVP
HHHHHHCCCCCCCCC
59.7621890473
608AcetylationKACLRNHQGPLPPVP
HHHHHHCCCCCCCCC
59.7619608861
608UbiquitinationKACLRNHQGPLPPVP
HHHHHHCCCCCCCCC
59.7623000965
608 (in isoform 2)Ubiquitination-59.7621890473
611UbiquitinationLRNHQGPLPPVPLHL
HHHCCCCCCCCCCHH
10.8121890473
611UbiquitinationLRNHQGPLPPVPLHL
HHHCCCCCCCCCCHH
10.8123000965
611 (in isoform 2)Ubiquitination-10.8121890473
627UbiquitinationNAPTRLMKDLGYGKG
CCCCHHHHHHCCCCC
55.1623000965
627 (in isoform 1)Ubiquitination-55.1621890473
631PhosphorylationRLMKDLGYGKGYKYN
HHHHHHCCCCCCCCC
23.9822817900
633AcetylationMKDLGYGKGYKYNPM
HHHHCCCCCCCCCCC
51.0519608861
633UbiquitinationMKDLGYGKGYKYNPM
HHHHCCCCCCCCCCC
51.0523000965
633 (in isoform 1)Ubiquitination-51.0521890473
635PhosphorylationDLGYGKGYKYNPMYS
HHCCCCCCCCCCCCC
17.4922817900
636UbiquitinationLGYGKGYKYNPMYSE
HCCCCCCCCCCCCCC
47.4121890473
636AcetylationLGYGKGYKYNPMYSE
HCCCCCCCCCCCCCC
47.4125953088
636NeddylationLGYGKGYKYNPMYSE
HCCCCCCCCCCCCCC
47.4132015554
636UbiquitinationLGYGKGYKYNPMYSE
HCCCCCCCCCCCCCC
47.4123000965
636 (in isoform 1)Ubiquitination-47.4121890473
636 (in isoform 2)Ubiquitination-47.4121890473
637PhosphorylationGYGKGYKYNPMYSEP
CCCCCCCCCCCCCCC
18.9327642862
641PhosphorylationGYKYNPMYSEPVDQE
CCCCCCCCCCCCCHH
15.9027642862
655MethylationEYLPEELRGVDFFKQ
HHCCHHHCCCCCHHH
46.50115920093
661NeddylationLRGVDFFKQRRC---
HCCCCCHHHCCC---
42.7832015554
661UbiquitinationLRGVDFFKQRRC---
HCCCCCHHHCCC---
42.7823000965
661 (in isoform 1)Ubiquitination-42.7821890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of WRIP1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of WRIP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of WRIP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
WRN_HUMANWRNphysical
11301316
UBP11_HUMANUSP11physical
19615732
NU107_HUMANNUP107physical
20676042
RAD18_HUMANRAD18physical
19556710
WRIP1_HUMANWRNIP1physical
15670210
DPOD1_HUMANPOLD1physical
15670210
TIF1B_HUMANTRIM28physical
22863883
UBC_HUMANUBCphysical
17550899
UBC_HUMANUBCphysical
25872870

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of WRIP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-633, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-85; SER-91; SER-92;THR-116 AND TYR-534, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-153, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91 AND SER-92, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; THR-85; SER-91;SER-92 AND THR-116, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-534 AND TYR-562, ANDMASS SPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Werner helicase-interacting protein 1 binds polyubiquitin via itszinc finger domain.";
Bish R.A., Myers M.P.;
J. Biol. Chem. 282:23184-23193(2007).
Cited for: SUMOYLATION, UBIQUITINATION AT LYS-81; LYS-141; LYS-225; LYS-301;LYS-310; LYS-316; LYS-322; LYS-335; LYS-482; LYS-627; LYS-633 ANDLYS-636, AND DOMAIN UBZ-TYPE ZINC FINGER.

TOP